In Depth Research on Global T Cell Lymphoma Market & Clinical Pipeline Insight

“Global T-Cell Lymphoma Market & Clinical Pipeline Insight” Report Highlight:

* Mechanism of T-Cell Lymphoma Therapeutics
* T-Cell Lymphoma Drug Market Overview
* T-Cell Lymphoma Drug Clinical Pipeline By Company & Phase
* T-Cell Lymphoma Drug Clinical Pipeline By Peripheral & Cutaneous T-cell Lymphoma
* T-Cell Lymphoma Drug Clinical Pipeline: 24 Drugs
* Orphan Designated T-Cell Lymphoma Drugs: 22 Drugs
* Marketed T Cell Lymphoma Drug Clinical Insight
* Marketed T Cell Lymphoma Drugs: 15 Drugs
* T-Cell Lymphoma Drug Market Future Prospects

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:https://www.kuickresearch.com/report-Global-T-Cell-Lymphoma-Market-&-Clinical-Pipeline-Insight.php

Table of Contents

1. T-Cell Lymphoma Market Analysis

2. Mechanism of T-Cell Lymphoma Therapeutics

3. T-Cell Lymphoma Drug Market Overview
3.1 Current Market Scenario
3.2 T Cell Lymphoma Clinical Pipeline Overview

4. T-Cell Lymphoma Drug Market Dynamics
4.1 Favorable Market Parameters
4.2 Commercialization Challenges

5. T-Cell Lymphoma Drug Market Future Prospects

6. T-Cell Lymphoma Drug Clinical Pipeline By Company & Phase
6.1 Research
6.2 Preclinical
6.3 Clinical
6.4 Phase-I
6.5 Phase-I/II
6.6 Phase-II
6.7 Phase-II/III
6.8 Phase-III

7. Marketed T-Cell Lymphoma Drug Clinical Insight
7.1 Belinostat (Beleodaq)
7.2 Denileukin Diftitox (ONTAK)
7.3 Mogamulizumab (Poteligeo)
7.4 Brentuximab Vedotin (Adcetris)
7.5 Pralatrexate (Difolta/Folotyn)
7.6 Interferon gamma 1a Biosimilar (Imunomax-γ)
7.7 Nelarabine (Arranon/ Atriance)
7.8 Vorinostat (Zolinza)
7.9 Romidepsin (Istodax)
7.10 Bexarotene Topical (Targretin Gel)
7.11 Bexarotene Oral (Targretin Oral)
7.12 Chlormethine (Ledaga/Valchlor
7.13 Methoxsalen Solution (UVADEX)
7.14 Mogamulizumab Companion Diagnostics (Poteligeo Test FCM/IHC)
7.15 Interferon alpha-2a (Roferon-A)

8. Discontinued & No Development Reported in T-Cell Lymphoma Drug in Clinical Pipeline
8.1 Discontinued
8.2 No Development Reported

9. Competitive Landscape
9.1 Actelion Pharmaceuticals
9.2 Allos Therapeutics
9.3 Astellas Pharma
9.4 BioCryst Pharmaceuticals
9.5 Bristol-Myers Squibb
9.6 Chipscreen Biosciences
9.7 Celgene Corporation
9.8 Eisai
9.9 Genmab
9.10 Galderma
9.11 Inovio Pharmaceuticals
9.12 Johnson & Johnson Pharmaceutical Research & Development
9.13 Karyopharm Therapeutics
9.14 Kyowa Hakko Kirin
9.15 Nippon Kayaku
9.16 Novartis
9.17 Neumedicines
9.18 Onyx Pharmaceuticals
9.19 Roche
9.20 Seattle Genetics
9.21 Shionogi
9.22 Soligenix
9.23 TetraLogic Pharmaceuticals
9.24 ZIOPHARM Oncology

Figure 1-1: Main Types of Blood Cancer
Figure 1-2: Types of White Blood Cells (WBC)
Figure 1-3: Types of Lymphoma
Figure 1-4: Major Type of T-Cell Lymphoma
Figure 1-5: Type of Anaplastic Large Cell Lymphoma
Figure 1-6: Type of Uncommon T-Cell Lymphomas
Figure 2-1: Extracorporeal Photopheresis (ECPP)
Figure 2-2: Mechanism of Bexarotene
Figure 2-3: Mechanism of Pralatrexate
Figure 2-4: Mechanism of Vorinostat
Figure 2-5: Mechanism of Denileukin Diftitox
Figure 2-6: Mechanism of Romidepsin
Figure 2-7: Mechanism of Alemtuzumab
Figure 3-1: T-Cell Lymphoma Pipeline by Phase(%), 2016
Figure 3-2: T-Cell Lymphoma Pipeline by Phase(Numbers), 2016
Figure 3-3: T-Cell Lymphoma Pipeline by Phase (%), 2016
Figure 3-4: T-Cell Lymphoma Pipeline by Phase (Numbers), 2016
Figure 4-1: T-Cell Lymphoma Drug Market Favorable Parameters
Figure 4-1: T-Cell Lymphoma Drug Market Commercialization Challenges

Table 1-1: Staging of T-Cell Lymphoma

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
India
+91-11-47067990

This release was published on openPR.